Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer
Elisabetta Munzone(Istituti di Ricovero e Cura a Carattere Scientifico), L. J. Blacher(International Breast Cancer Study Group), Lorenzo Gianni, Rita Pfister(International Breast Cancer Study Group), Saverio Cinieri(Ospedale A. Perrino), Fabio Puglisi(University of Udine), Sherene Loi(The University of Melbourne), Claudio Chini(Aziende Socio Sanitarie Territoriale dei Sette Laghi), Adriana Gasca(International Breast Cancer Study Group), Rolf A. Stahel(International Breast Cancer Study Group), Daniela Celotto(International Breast Cancer Study Group), Meredith M. Regan(Dana-Farber Cancer Institute), Elisabetta Cretella(Ospedale di Bolzano), Claudio Zamagni(Policlinico S.Orsola-Malpighi), Daniele Generali(University of Trieste), Carmen Comune(International Breast Cancer Study Group), Barbara Ruepp(The Coordinating Center), Colleen Bouzan(International Breast Cancer Study Group), Nino Giacomelli(University of Zurich), Richard D. Gelber(Harvard University), Stefan Aebi(University of Lucerne), Mirjam Schneider(International Breast Cancer Study Group), Subrina Farah(Dana-Farber Cancer Institute), Sanjay Popat(Royal Marsden NHS Foundation Trust), Roswitha Kammler(International Breast Cancer Study Group), Michela Palleschi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Marco Colleoni(European Institute of Oncology), Fausto Petrelli(Azienda Ospedaliera Treviglio), Emilia Montagna, Sandra Troesch(International Breast Cancer Study Group), Keith McGregor(Assistance Publique Hôpitaux de Marseille), R. Rosell(Instituto Oncológico Dr. Rosell), Enrico Campadelli(Ospedale per gli Infermi), Carmelo Bengala(Ospedale Misericordia - Grosseto), Anita Hiltbrunner(Dana-Farber Cancer Institute), Anne Carrer-Wagner(International Breast Cancer Study Group), Elizabeth Rugiati(International Breast Cancer Study Group), Laura Orlando, Judith Schroeder(International Breast Cancer Study Group), Monica Ruggeri(International Breast Cancer Study Group), Holly Shaw(International Breast Cancer Study Group), Angelo Di Leo(Hospital of Prato), Zhuoxin Sun(Dana-Farber Cancer Institute), Heidi Roschitzki(International Breast Cancer Study Group), G Achille(International Breast Cancer Study Group), Elena Collovà(Aziende Socio Sanitarie Territoriale Ovest Milanese), Solange Peters(University Hospital of Lausanne), R. Shi(Dana-Farber Cancer Institute)
Cited by 37
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k